The emergence of the novel coronavirus disease 2019 (COVID-19) presents unique challenges for oncology patients. In addition to effects on access to care, initial studies have demonstrated an increased risk of infection and death in cancer patients [5]. COVID-19 has also been linked to hypercoagulability and elevated cerebrovascular accidents rates [3, 6, 9]; however, little is known regarding the impact of COVID-19-associated coagulopathy on tumor biology. Malignancies are well associated with hypercoagulation, varying by age and tumor type. Brain tumors are associated with high risk for thromboembolism in adults but not in children [1, 8]. Here, we discuss the case of a young adult with a thalamic high-grade glioma, COVID-19-associated coagulopathy, and histopathologic evidence of extensive vascular thrombosis within the tumor microenvironment.
A 21-year-old woman presented with headaches, blurry vision, and vomiting. Her neurologic examination showed no abnormalities, and the patient was diagnosed with tension-type headache. Two months later, she experienced a syncopal episode. Head CT demonstrated a large (4.3 cm) supratentorial thalamic mass causing obstructive hydrocephalus. She subsequently decompensated from herniation and underwent emergent ventricular drain placement. Post-operative head CT and MRI demonstrated successful drain placement, but exhibited marked hemorrhage in the tumor and ventricles, with displacement of the septum pellucidum (Figs. 1a, b and Supplementary Figure. 1a, online resource). The patient tested positive for SARS-CoV-2 by nasopharyngeal swab and exhibited classic findings of COVID-19-associated coagulopathy including elevated D-dimer levels (Fig. 1c), without changes in prothrombin or activated-partial-thromboplastin time (Supplementary Table 1, online resource) [3]. She exhibited no respiratory symptoms, and a chest radiograph demonstrated no evidence of lung disease.
Biopsy demonstrated a high-grade glial tumor (Fig. 1d) expressing GFAP (Fig. 1e). Tumor cells showed H3K27M staining (Fig. 1f), reduced H3K27me3, and high Ki-67 (Supplementary Figure.1b-c, online resource). Notably, the tumor showed multiple areas of hemorrhage, thrombosed blood vessels, and microthrombi with fibrin deposition, confirmed by a PTAH stain (Figs. 1g–l and S1d-l, online resource). The tumor exhibited parenchymal and perivascular macrophage infiltration (Figs. 1m–n) and rare CD4-positive T cells (Fig. 1o). SARS-CoV-2 in situ hybridization was negative (Supplementary Figures. 1m–n, online resource).
Microthrombi in IDH-WT glioblastomas are associated with necrosis, hypoxic niches, and development of treatment resistance. Intriguingly, IDH-mutant gliomas show lower frequencies of microthrombi [7]. Because the frequency of thrombosis in H3K27M gliomas is unknown, we evaluated ten cases, finding far fewer microthrombi (mean = 2.9, median = 0.5) than the current case (> 40, Supplementary Figure. 1o, online resource). Moreover, brainstem gliomas in children and young adults have low frequencies of intratumoral hemorrhage [2].
Recent reports suggest a unique predisposition of the brain to thrombosis in COVID-19 infections attributed to a cytokine storm syndrome [4, 6]. Given the poor association between intratumoral microthrombi and overall prognosis in gliomas, our case raises a critical question concerning the impact of COVID-19-associated coagulopathy on tumor biology, the immune microenvironment, and, in this case, the patient’s clinical course. Our case poses the hypothesis that COVID-19-associated coagulopathy could affect long-term tumor behavior and disease progression in cancer in a manner yet unrecognized.
References
Athale U, Siciliano S, Thabane L, Pai N, Cox S, Lathia A et al (2008) Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer 51:792–797. https://doi.org/10.1002/pbc.21734
Broniscer A, Laningham FH, Kocak M, Krasin MJ, Fouladi M, Merchant TE et al (2006) Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma. Cancer 106:1364–1371. https://doi.org/10.1002/cncr.21749
Colling ME, Kanthi Y (2020) COVID-19-associated coagulopathy: an exploration of mechanisms. Vasc Med. https://doi.org/10.1177/1358863X20932640
Coolen T, Lolli V, Sadeghi N, Rovaï A, Trotta N, Taccone FS et al (2020) Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology. https://doi.org/10.1212/WNL.0000000000010116
Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A et al (2020) Case fatality rate of cancer patients with covid-19 in a New York hospital system. Cancer Discov. https://doi.org/10.1158/2159-8290.cd-20-0516
Reichard RR, Kashani KB, Boire NA, Constantopoulos E, Guo Y, Lucchinetti CF (2020) Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol 140:1–6. https://doi.org/10.1007/s00401-020-02166-2
Unruh D, Schwarze SR, Khoury L, Thomas C, Wu M, Chen L et al (2016) Mutant IDH1 and thrombosis in gliomas. Acta Neuropathol 132:917–930. https://doi.org/10.1007/s00401-016-1620-7
Walker AJ, West J, Card TR, Crooks C, Grainge MJ (2012) Rate of venous thromboembolism by cancer type compared to the general population using multiple linked databases. Thromb Res 129:S155–S156. https://doi.org/10.1016/S0049-3848(12)70036-1
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062. https://doi.org/10.1016/s0140-6736(20)30566-3
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Pun, M., Haggerty-Skeans, J., Pratt, D. et al. H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in a young adult with COVID-19-associated coagulopathy. Acta Neuropathol 140, 227–229 (2020). https://doi.org/10.1007/s00401-020-02184-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-020-02184-0